Present Situation and Countermeasures of Conflict between Off-label Drug Use and Judicial Evaluation
10.6039/j.issn.1001-0408.2017.28.02
- VernacularTitle:超说明书用药与司法评判冲突的现状及对策
- Author:
Bin DENG
1
;
Binghua WEI
;
Xiaodan HONG
;
Lei TANG
;
Zhong FU
Author Information
1. 中山大学附属第一医院药学部
- Keywords:
Off-label drug use;
Medical disputes;
Judicial practice
- From:
China Pharmacy
2017;28(28):3892-3895
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To provide suggestions for standardizing and protecting the off-label drug use. METHODS:Accord-ing to the field interviews with pharmacists and lawyers,the present situation of off-label drug use in judicial practice at home and abroad,and relevant countermeasures were put forward. RESULTS & CONCLUSIONS:At present,there was no mechanism for off-label drug use in the laws and regulations in China;there was only"special circumstances"statement in sporadic terms,while lacking explanation. In judicial practice of medical disputes,judges had different identifications in various references,such as the le-gality of routine and guidelines,teaching medical materials,clinical pathways,and internal regulations of medical institutions pre-pared by authoritative departments. Meanwhile,the judicial environment of hearing cases by identification made the off-label drug use had impartial adjudication. Legislation in 6 countries,including America,allows reasonable off-label drug use;FDA required off-label drug use must be for the benefit of patients rather than clinical trials,and it also should protect the patient's right to know. China should establish the authority specification of off-label drug use,providing scientific identification procedures,protect the patient 's informed consent by law. Medical institutions should develop relevant management system and processes to regulate medical prac-tices and ensure off-label drug use in line with the interests of doctors and patients.
